Int. J. Mol. Sci. 2013, 14(5), 10307-10331; doi:10.3390/ijms140510307
Review

Methylated DNA and microRNA in Body Fluids as Biomarkers for Cancer Detection

Laboratory of Cancer Biology, Department of Medical Oncology, Institute of Clinical Science, Sir Runrun Shaw Hospital, Medical School of Zhejiang University, Hangzhou 310029, China
* Author to whom correspondence should be addressed.
Received: 11 March 2013; in revised form: 1 April 2013 / Accepted: 25 April 2013 / Published: 16 May 2013
(This article belongs to the Special Issue Advances in Cancer Diagnosis)
PDF Full-text Download PDF Full-Text [271 KB, uploaded 16 May 2013 11:30 CEST]
Abstract: Epigenetic alterations including DNA methylation and microRNAs (miRNAs) play important roles in the initiation and progression of human cancers. As the extensively studied epigenetic changes in tumors, DNA methylation and miRNAs are the most potential epigenetic biomarkers for cancer diagnosis. After the identification of circulating cell-free nuclear acids, increasing evidence demonstrated great potential of cell-free epigenetic biomarkers in the blood or other body fluids for cancer detection.
Keywords: cancer; biomarker; DNA methylation; miRNAs

Article Statistics

Load and display the download statistics.

Citations to this Article

Cite This Article

MDPI and ACS Style

Ma, Y.; Wang, X.; Jin, H. Methylated DNA and microRNA in Body Fluids as Biomarkers for Cancer Detection. Int. J. Mol. Sci. 2013, 14, 10307-10331.

AMA Style

Ma Y, Wang X, Jin H. Methylated DNA and microRNA in Body Fluids as Biomarkers for Cancer Detection. International Journal of Molecular Sciences. 2013; 14(5):10307-10331.

Chicago/Turabian Style

Ma, Yanning; Wang, Xian; Jin, Hongchuan. 2013. "Methylated DNA and microRNA in Body Fluids as Biomarkers for Cancer Detection." Int. J. Mol. Sci. 14, no. 5: 10307-10331.

Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert